ASCO GU 2019: Pembrolizumab plus axitinib versus sunitinib for untreated metastatic RCC
The results from the following study were presented at the [...]
The results from the following study were presented at the [...]
Further survival data has been released from the phase 3 [...]
Using gene profiling, a recent study published in Cancer Discovery [...]
Results of the phase 3 SURTIME trial comparing pretreatment with [...]
The following review of the literature for first-line treatment of [...]
This review paper was presented at the European Association of [...]
The European Commission has approved the nivolumab plus ipilimumab combination [...]
Results from the phase 3 CARMENA study, published in the [...]
This multicentre analysis of axitinib versus sunitinib used as first-line [...]
The following article from Practice Update discusses the JAVELIN Renal [...]